A concise update on the status of liver transplantation for hepatitis B virus: The challenges in 2002

被引：24

作者：

Vargas, HE

Dodson, FS

Rakela, J

机构：

[1] Mayo Clin Scottsdale, Div Transplantat Med, Phoenix, AZ USA

[2] Alton Ochsner Med Fdn & Ochsner Clin, Dept Surg, New Orleans, LA 70121 USA

来源：

LIVER TRANSPLANTATION | 2002年 / 8卷 / 01期

关键词：

D O I：

10.1053/jlts.2002.29765

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Significant improvements in both patient and graft survival after orthotopic Liver transplantation (OLT) for hepatitis B virus (HBV)-related liver failure have been made during the last decade. Recurrence of HBV infection has decreased, even in high-risk patients. Despite ongoing progress, challenges remain for the next millennium, including the determination of cost-effective dosing strategies, treatment of HBV infection in liver transplant recipients, and ramifications of the use of new antiviral agents, specifically, the appearance of resistant strains. This review summarizes the relevant history of OLT for chronic viral hepatitis B, details accepted preventive and therapeutic treatments, and discusses ongoing experimental trials. Emphasis also is placed on new approaches in transplantation as they impact on the care of HBV-infected patients.

引用

收藏

页码：2 / 9

页数：8

相关论文

共 89 条

[1]

Ahmad J, 2000, HEPATOLOGY, V32, p292A

[2] Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B [J].

Angus, PW ;

McCaughan, GW ;

Gane, EJ ;

Crawford, DHG ;

Harley, H .

LIVER TRANSPLANTATION, 2000, 6 (04) :429-433

[3] Detection of different viral strains of hepatitis B virus in chronically infected children after seroconversion from HBsAg to anti-HBs indicating viral persistence [J].

Bahn, A ;

Gerner, P ;

Martine, U ;

Bortolotti, F ;

Wirth, S .

JOURNAL OF HEPATOLOGY, 1997, 27 (06) :973-978

[4] Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation [J].

Bain, VG ;

Kneteman, NM ;

Ma, MM ;

Gutfreund, K ;

Shapiro, JA ;

Fischer, K ;

Tipples, G ;

Lee, H ;

Jewell, LD ;

Tyrrell, DL .

TRANSPLANTATION, 1996, 62 (10) :1456-1462

[5]

Balan V, 1999, HEPATOLOGY, V30, p346A

[6] FIBROSING CYTOLYTIC LIVER-FAILURE SECONDARY TO RECURRENT HEPATITIS-B AFTER LIVER-TRANSPLANTATION [J].

BENNER, KG ;

LEE, RG ;

KEEFFE, EB ;

LOPEZ, RR ;

SASAKI, AW ;

PINSON, CW .

GASTROENTEROLOGY, 1992, 103 (04) :1307-1312

[7] Reactivation of hepatitis B after transplantation in patients with pre-existing anti-hepatitis B surface antigen antibodies - Report on three cases and review of the literature [J].

Blanpain, C ;

Knoop, C ;

Delforge, ML ;

Antoine, M ;

Peny, MO ;

Liesnard, C ;

Vereerstraeten, P ;

Cogan, E ;

Adler, M ;

Abramowicz, D .

TRANSPLANTATION, 1998, 66 (07) :883-886

[8] EMERGENCE OF HEPATITIS-B VIRUS S-GENE MUTANT IN A LIVER-TRANSPLANT RECIPIENT [J].

CARIANI, E ;

RAVAGGI, A ;

TANZI, E ;

ROMANO, L ;

FIORDALISI, G ;

BELLATI, G ;

CACCAMO, L ;

GALMARINI, D ;

ALBERTINI, A ;

ZANETTI, A .

JOURNAL OF MEDICAL VIROLOGY, 1995, 47 (04) :410-415

[9] Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis [J].

Carman, WF ;

Trautwein, C ;

vanDeursen, FJ ;

Colman, K ;

Dornan, E ;

McIntyre, G ;

Waters, J ;

Kliem, V ;

Muller, R ;

Thomas, HC ;

Mannis, MP .

HEPATOLOGY, 1996, 24 (03) :489-493

[10] VACCINE-INDUCED ESCAPE MUTANT OF HEPATITIS-B VIRUS [J].

CARMAN, WF ;

ZANETTI, AR ;

KARAYIANNIS, P ;

WATERS, J ;

MANZILLO, G ;

TANZI, E ;

ZUCKERMAN, AJ ;

THOMAS, HC .

LANCET, 1990, 336 (8711) :325-329

← 1 2 3 4 5 6 7 8 9 →